Alarming Decline in Childhood Cancer Survival Rates in Pakistan: A Comprehensive Report
Synopsis
Key Takeaways
Islamabad, Feb 23 (NationPress) Despite the fact that childhood cancer survival rates in affluent countries exceed 80%, this figure plummets to under 30% in lower and middle-income nations such as Pakistan. This alarming decline is attributed to delays in recognizing symptoms, inadequate quality of supportive care, a shortage of trained specialists, limited access to specialized treatment, and treatment abandonment, as highlighted in a recent report.
Approximately 10,000 children are diagnosed with cancer annually in Pakistan, according to an editorial in the country’s prominent daily, The Express Tribune. Tragically, many of these children could have survived had they been born in countries with superior resources and healthcare management.
The editorial states, “The bleak survival rate in Pakistan is primarily due to delayed symptom recognition, insufficient quality of supportive care, a lack of trained professionals, restricted access to specialized treatment facilities, and significant rates of treatment abandonment.”
Delays in the diagnosis of childhood cancer are prevalent at nearly all care levels. A lack of awareness regarding symptoms leads to initial delays in seeking medical advice. Afterward, there is a lag in referring the child to an oncology center, followed by delays in arriving at a final diagnosis due to limited diagnostic capabilities and overwhelmed hospitals, as per the insights from The Express Tribune.
During treatment, families often face challenges with inexperienced healthcare providers and encounter difficulties accessing medical facilities. Those living in rural areas are at an even greater disadvantage, as specialized care is often unavailable in such regions.
Even when children do manage to reach medical facilities, the exorbitant costs of advanced treatments, life-saving medications, and basic primary care make it unfeasible for most families to exhaust all available resources.